Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by davgroon Feb 11, 2023 11:53am
782 Views
Post# 35281425

Aurora Cannabis Target Price Lowered to $1.75 at CIBC

Aurora Cannabis Target Price Lowered to $1.75 at CIBC2023-02-10 10:12:30 AM ET (MT Newswires) 

10:12 AM EST, 02/10/2023 (MT Newswires) -- CIBC Capital Markets lowered its price target on Aurora Cannabis Inc. (ACB.TO) to $1.75 from $2.25 on Friday.
 
Analyst John Zamparo maintained a Neutral rating on shares of the Canadian cannabis producer.
 
"Aurora's strength in high-quality markets provides reason for optimism, and healthy margins combined with recent cost cuts have resulted in significant improvements," Zamparo said in a note to clients.
 
"Ultimately though, until ACB becomes self-funded and commits to no further equity dilution, we do not see significant upside in the stock, even if valuation and the balance sheet are more attractive than most peers," the analyst said.
<< Previous
Bullboard Posts
Next >>